Evaluation of the prognostic significance of RACGAP1, Ki67, and TOP2A mRNA expression in high-risk early breast cancer.

被引：0
|
作者：
Pliarchopoulou, Kyriaki
Gogas, Helen
Papadimitriou, Christos A.
Wirtz, Ralph M.
Kouvalseas, George
Timotheadou, Eleni
Slavridi, Flora
Christodoulou, Christos
Koutras, Angelos
Pisanidis, Nikolaos
Pentheroudakis, George E.
Bafaloukos, Dimitris
Samantas, Epaminontas
Kalogeras, Konstantine T.
Dimopoulos, Meletios A.
Pectasides, Dimitrios G.
Fountzilas, George
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece
[2] STRATIFYER Mol Pathol GmbH, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
    Karin Milde-Langosch
    Thomas Karn
    Volkmar Müller
    Isabell Witzel
    Achim Rody
    Markus Schmidt
    Ralph M. Wirtz
    Breast Cancer Research and Treatment, 2013, 137 : 57 - 67
  • [2] Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
    Milde-Langosch, Karin
    Karn, Thomas
    Mueller, Volkmar
    Witzel, Isabell
    Rody, Achim
    Schmidt, Markus
    Wirtz, Ralph M.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 57 - 67
  • [3] Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer
    Sahin, Sevinc
    Gonul, Ipek Isik
    Cakir, Asli
    Seckin, Selda
    Uluoglu, Omer
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (07) : 607 - 613
  • [4] Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
    K. Pliarchopoulou
    K. T. Kalogeras
    R. Kronenwett
    R. M. Wirtz
    A. G. Eleftheraki
    A. Batistatou
    M. Bobos
    N. Soupos
    G. Polychronidou
    H. Gogas
    E. Samantas
    C. Christodoulou
    T. Makatsoris
    N. Pavlidis
    D. Pectasides
    G. Fountzilas
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 245 - 255
  • [5] Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
    Pliarchopoulou, K.
    Kalogeras, K. T.
    Kronenwett, R.
    Wirtz, R. M.
    Eleftheraki, A. G.
    Batistatou, A.
    Bobos, M.
    Soupos, N.
    Polychronidou, G.
    Gogas, H.
    Samantas, E.
    Christodoulou, C.
    Makatsoris, T.
    Pavlidis, N.
    Pectasides, D.
    Fountzilas, G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 245 - 255
  • [6] Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
    Neubauer, Elisa
    Wirtz, Ralph M.
    Kaemmerer, Daniel
    Athelogou, Maria
    Schmidt, Lydia
    Saenger, Joerg
    Lupp, Amelie
    ONCOTARGET, 2016, 7 (27) : 41959 - 41973
  • [7] PROGNOSTIC SIGNIFICANCE OF KI67 PROTEIN EXPRESSION IN METASTATIC BREAST CANCER SURVIVAL
    Todorovic-Rakovic, Natasa
    Kanjer, Ksenija
    Neskovic-Konstantinovic, Zora
    BREAST, 2015, 24 : S73 - S73
  • [8] The Assessment of Proliferation in BP-NEN Entities Based on the Three Proliferation Markers Ki-67, TOP2A and RacGAP1
    Specht, E.
    Wirtz, R.
    Kaemmerer, D.
    Schulz, S.
    Saenger, J.
    Lupp, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 251 - 251
  • [9] TOP2A mRNA expression in HER2 negative breast cancer.
    Gennari, A.
    Sormani, M.
    Pfeffer, U.
    Morandi, L.
    Mustacchi, G.
    Danesi, R.
    Mirisola, V
    Bruzzi, P.
    CANCER RESEARCH, 2009, 69 (02) : 357S - 357S
  • [10] Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
    Psyrri, A.
    Kalogeras, K. T.
    Kronenwett, R.
    Wirtz, R. M.
    Batistatou, A.
    Bournakis, E.
    Timotheadou, E.
    Gogas, H.
    Aravantinos, G.
    Christodoulou, C.
    Makatsoris, T.
    Linardou, H.
    Pectasides, D.
    Pavlidis, N.
    Economopoulos, T.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1422 - 1427
12345